Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26856587 |
BR |
2 | |
Hypersensitivity, Pruritus, Erythema, Off label use, Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 702 | 26856647 |
US |
2 | |
Hyperphagia, Erythema, Swelling, Pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 703 | 26856797 |
US |
86 | 2 |
Burning sensation, Erythema, Product adhesion issue, |
||||
OXYBUTYNIN, CALCIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, CEVIMELINE HYDROCHLORIDE, CEVIMELINE, SIMVASTATIN, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, IRBESARTAN, |
||||
| 704 | 26857167 |
US |
2 | |
Drug ineffective, Pruritus, Erythema, Pain, Thermal burn, |
||||
USTEKINUMAB, |
||||
| 705 | 26857231 |
US |
68 | 2 |
Pruritus, Skin burning sensation, Skin exfoliation, Erythema, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 706 | 26861503 |
67 | ||
Injury associated with device, Wrong technique in device usage process, Accidental exposure to product, Pain, Erythema, Hypoaesthesia, |
||||
EVOLOCUMAB, |
||||
| 707 | 26846776 |
US |
1 | |
Gastrooesophageal reflux disease, Dyspnoea, Erythema, Asthma, |
||||
DUPILUMAB, |
||||
| 708 | 26847023 |
US |
47 | 1 |
Skin irritation, Swelling, Erythema, Pain in extremity, Pruritus, |
||||
PEGUNIGALSIDASE ALFA, |
||||
| 709 | 26847031 |
JP |
65 | |
Toxic skin eruption, Erythema, Nasopharyngitis, |
||||
BETAMETHASONE DIPROPIONATE, |
||||
| 710 | 26847103 |
|||
Swelling face, Peripheral swelling, Eye swelling, Pruritus, Erythema, |
||||
PORFIMER SODIUM, |
||||
| 711 | 26847337 |
CO |
76 | 2 |
Bunion operation, Off label use, Postoperative wound infection, Erythema, Inflammation, |
||||
CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, NAPROXEN, NAPROXEN SODIUM, TRIMETHOPRIM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEFLUNOMIDE, |
||||
| 712 | 26847419 |
EU |
46 | 2 |
Blood urine, Constipation, Insomnia, Nasal dryness, Epistaxis, Rhinorrhoea, Productive cough, Erythema, Nail disorder, Nail discolouration, Pain in extremity, Heart rate increased, Oropharyngeal pain, Taste disorder, Lacrimation increased, Ocular hyperaemia, Musculoskeletal stiffness, Oedema peripheral, Myalgia, Musculoskeletal pain, Thirst, Diarrhoea, Pyrexia, Liver function test increased, Fatigue, Mobility decreased, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, PEGFILGRASTIM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, KETOPROFEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 713 | 26847550 |
US |
66 | 2 |
Rash, Erythema, Pruritus, |
||||
IOHEXOL, POLYMYXIN B SULFATE, |
||||
| 714 | 26847824 |
US |
79 | 2 |
Erythema, Peripheral swelling, Arthralgia, Dizziness, Hypotension, Heart rate decreased, Abdominal pain, |
||||
IRON SUCROSE, |
||||
| 715 | 26848198 |
US |
14 | 2 |
Erythema, Eczema, |
||||
TRALOKINUMAB-LDRM, NEMOLIZUMAB-ILTO, |
||||
| 716 | 26848390 |
US |
2 | |
Peripheral swelling, Erythema, Vomiting, Nausea, Pain in extremity, |
||||
VEDOLIZUMAB, |
||||
| 717 | 26848469 |
US |
66 | 2 |
Illness, Skin burning sensation, Erythema, Headache, Nausea, Flatulence, Vomiting, Fatigue, Abdominal distension, |
||||
ORFORGLIPRON, |
||||
| 718 | 26848474 |
GB |
64 | 2 |
Swelling face, Flushing, Erythema, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FEXOFENADINE, |
||||
| 719 | 26848591 |
US |
2 | |
Dermatitis atopic, Rash, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 720 | 26848594 |
US |
10 | 2 |
Dermatitis atopic, Erythema, Skin exfoliation, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 721 | 26848712 |
US |
74 | 1 |
Balance disorder, Dizziness, Feeling drunk, Periorbital swelling, Erythema, Flushing, Fatigue, |
||||
POMALIDOMIDE, SELINEXOR, |
||||
| 722 | 26848779 |
GB |
64 | |
Swelling face, Flushing, Erythema, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FEXOFENADINE, |
||||
| 723 | 26848890 |
CO |
10 | 2 |
Urticaria, Pruritus, Nasal oedema, Hypoaesthesia, Hypoaesthesia, Erythema, Eye swelling, Dyspnoea, Malaise, Crying, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 724 | 26848990 |
US |
29 | 2 |
Eczema, Erythema, Dry skin, |
||||
DUPILUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, |
||||
| 725 | 26849038 |
US |
2 | |
Pruritus, Erythema, Skin exfoliation, Blister, |
||||
POLIDOCANOL, POLIDOCANOL, POLIDOCANOL, POLIDOCANOL, POLIDOCANOL, |
||||
| 726 | 26849151 |
EU |
1 | |
Mouth swelling, Erythema, Oedema mucosal, |
||||
DENOSUMAB, |
||||
| 727 | 26849160 |
EU |
57 | 2 |
Cellulitis, Erythema, Pyrexia, Sepsis, |
||||
FULVESTRANT, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 728 | 26849161 |
40 | 1 | |
Paraesthesia, Erythema, Fatigue, Pruritus, Dyspnoea, Oxygen saturation decreased, |
||||
IOPROMIDE, IOPROMIDE, CLARITHROMYCIN, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 729 | 26849262 |
US |
2 | |
Craniocerebral injury, Headache, Concussion, Fall, Fatigue, Middle insomnia, Nocturia, Hypersomnia, Sedation, Erythema, Nervousness, Anxiety, Dizziness, Tremor, Hyperhidrosis, Terminal insomnia, |
||||
QUETIAPINE, QUETIAPINE, QUETIAPINE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LAMOTRIGINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROGESTERONE, PROPRANOLOL HYDROCHLORIDE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 730 | 26849402 |
US |
2 | |
Erythema, Pruritus, Skin burning sensation, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 731 | 26849409 |
US |
77 | 1 |
Erythema, Dandruff, Pruritus, |
||||
DUPILUMAB, |
||||
| 732 | 26849521 |
AU |
35 | 2 |
Hypotension, Bronchospasm, Dyspnoea, Wheezing, Erythema, |
||||
| 733 | 26849550 |
CN |
51 | 1 |
Papule, Erythema, Rash macular, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 734 | 26849675 |
US |
61 | 2 |
Erythema, Pruritus, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 735 | 26849971 |
US |
2 | |
Pruritus, Breast pain, Breast swelling, Erythema, Rash, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 736 | 26850058 |
EU |
69 | 2 |
Acute haemorrhagic ulcerative colitis, Erythema, |
||||
TRAMETINIB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 737 | 26850076 |
US |
26 | 2 |
Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 738 | 26850090 |
US |
2 | |
Flushing, Nausea, Headache, Erythema, Flushing, Chills, |
||||
AVALGLUCOSIDASE ALFA-NGPT, AVALGLUCOSIDASE ALFA-NGPT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FAMOTIDINE, DEXTROSE MONOHYDRATE, DEXTROSE, LIDOCAINE, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 739 | 26850121 |
US |
2 | |
Rash macular, Tenderness, Vulvovaginal mycotic infection, Erythema, |
||||
DUPILUMAB, |
||||
| 740 | 26850141 |
US |
73 | 1 |
Rash, Erythema, Diarrhoea, Constipation, Paraesthesia, Arthralgia, Skin swelling, Product use in unapproved indication, |
||||
DUPILUMAB, RESMETIROM, ROSUVASTATIN, |
||||
| 741 | 26850785 |
US |
62 | 2 |
Peripheral swelling, Erythema, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 742 | 26850990 |
CN |
38 | 1 |
Skin swelling, Dermatitis acneiform, Erythema, Pruritus, |
||||
CETUXIMAB, |
||||
| 743 | 26851001 |
CA |
76 | 1 |
Erythema, Urticaria, Rash maculo-papular, Pruritus, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LINAGLIPTIN, |
||||
| 744 | 26851021 |
EU |
1 | |
Erythema, Off label use, |
||||
ANAKINRA, |
||||
| 745 | 26851205 |
US |
44 | 1 |
Dermatitis bullous, Photosensitivity reaction, Pain, Rash, Erythema, Tenderness, Pruritus, Blister, Skin exfoliation, Skin lesion, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, |
||||
| 746 | 26851369 |
US |
60 | 2 |
Hordeolum, Urticaria, Pruritus, Erythema, Skin swelling, Injection site erythema, Injection site swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 747 | 26851673 |
US |
1 | |
Facial pain, Erythema, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), |
||||
| 748 | 26851895 |
US |
2 | |
Eye irritation, Erythema, Therapeutic response decreased, Product substitution issue, |
||||
TRAVOPROST, TRAVOPROST (ISOMER FREE), TRAVOPROST, |
||||
| 749 | 26861276 |
68 | 2 | |
Photosensitivity reaction, Skin discolouration, Urticaria, Erythema, Lip swelling, |
||||
GLATIRAMER, |
||||
| 750 | 26846042 |
EU |
80 | 1 |
Photosensitivity reaction, Skin injury, Erythema, Early satiety, Pruritus, Rash, Decreased appetite, |
||||
PIRFENIDONE, |
||||
| 751 | 26845057 |
US |
31 | 2 |
Rash, Erythema, Lymphadenopathy, Oropharyngeal pain, |
||||
TEPLIZUMAB-MZWV, |
||||
| 752 | 26845067 |
US |
54 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 753 | 26845068 |
US |
41 | 1 |
Erythema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FEXOFENADINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 754 | 26845157 |
US |
5 | 1 |
Tongue coated, Coating in mouth, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 755 | 26845210 |
US |
59 | 2 |
Hangnail, Erythema, Injection site pain, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 756 | 26845231 |
US |
14 | 2 |
Urticaria, Erythema, |
||||
DUPILUMAB, |
||||
| 757 | 26845265 |
US |
2 | |
Bladder cancer, Injection site pain, Erythema, Skin plaque, Wrong technique in product usage process, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 758 | 26845330 |
US |
4 | 1 |
Skin irritation, Erythema, Rash, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 759 | 26845344 |
US |
45 | 2 |
Pruritus, Erythema, Skin warm, |
||||
DUPILUMAB, |
||||
| 760 | 26845345 |
US |
||
Erythema, |
||||
BELIMUMAB, |
||||
| 761 | 26845492 |
US |
57 | 1 |
Erythema, Swelling face, |
||||
DUPILUMAB, |
||||
| 762 | 26845506 |
CN |
65 | 1 |
Langerhans^ cell histiocytosis, Erythema, Skin exfoliation, Rash, Dermatopathic lymphadenopathy, Red blood cell sedimentation rate increased, Blood immunoglobulin E increased, Blood immunoglobulin G increased, Eosinophil count increased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 763 | 26845631 |
US |
2 | |
Weight fluctuation, Rash, Blister, Erythema, Sinusitis, Rosacea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FEXOFENADINE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALLOPURINOL, MAGNESIUM OXIDE, TADALAFIL, FLUTICASONE PROPIONATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SPIRONOLACTONE, GABAPENTIN, MECLIZINE HYDROCHLORIDE, DIMENHYDRINATE, DICYCLOMINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, |
||||
| 764 | 26839684 |
US |
1 | |
Hallucination, Fall, Urinary tract infection, Erythema, Injection site infection, Rash, Balance disorder, Dizziness, Joint swelling, Underdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, FOSCARBIDOPA/FOSLEVODOPA, PANTOPRAZOLE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BENZTROPINE MESYLATE, BENZTROPINE, CARBIDOPA AND LEVODOPA, |
||||
| 765 | 26839694 |
CA |
59 | 1 |
Thrombosis, Heart rate irregular, Sinusitis, Erythema, Swelling, Arthralgia, |
||||
ZOLEDRONIC ACID, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LORAZEPAM, CELECOXIB, DESOXIMETASONE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, USTEKINUMAB, ALBUTEROL SULFATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 766 | 26839709 |
US |
44 | 1 |
Dermatitis bullous, Photosensitivity reaction, Pain, Rash, Erythema, Tenderness, Pruritus, Blister, Skin exfoliation, Skin lesion, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 767 | 26839839 |
US |
57 | 2 |
Arthralgia, Pain, Injection site pain, Injection site pruritus, Injection site warmth, Peripheral swelling, Erythema, Pyrexia, |
||||
DUPILUMAB, |
||||
| 768 | 26839840 |
US |
91 | 2 |
Pruritus, Erythema, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, VALSARTAN, VALSARTAN ORAL, EZETIMIBE, |
||||
| 769 | 26839900 |
TW |
51 | 2 |
Erythema, Skin exfoliation, Pruritus, |
||||
LACOSAMIDE, LEVETIRACETAM, PERAMPANEL, |
||||
| 770 | 26839956 |
US |
2 | |
Neuropathy peripheral, Gait disturbance, Sciatica, Off label use, Erythema, Paraesthesia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 771 | 26840024 |
US |
33 | 1 |
Rash, Erythema, Skin swelling, Skin irritation, Rosacea, |
||||
DUPILUMAB, |
||||
| 772 | 26840252 |
US |
61 | 2 |
Initial insomnia, Eczema, Pruritus, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 773 | 26840265 |
US |
1 | |
Depression, Erythema, Rash, Hypersensitivity, Extra dose administered, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, LOVASTATIN, VALPROIC ACID, ALPRAZOLAM, |
||||
| 774 | 26840321 |
CA |
60 | |
Blood pressure increased, Erythema, Tongue pruritus, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 775 | 26840830 |
CA |
44 | 1 |
Acrochordon, Anaemia, Atrial fibrillation, Blood iron decreased, Cardiac pacemaker insertion, Cellulitis, Choking, Erythema, Fluid retention, Granuloma, Hepatic enzyme abnormal, Herpes zoster, Incision site erythema, Infusion site reaction, Oesophageal candidiasis, Papule, Pleural effusion, Postoperative wound infection, Skin exfoliation, Skin irritation, Stoma site haemorrhage, Stoma site infection, Stoma site inflammation, Suture related complication, Pruritus, Eye irritation, Abdominal pain upper, Visual impairment, Weight increased, |
||||
METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AMLODIPINE, AMLODIPINE, APIXABAN, DAPAGLIFLOZIN, IRON, IRON, SPIRONOLACTONE, |
||||
| 776 | 26840861 |
US |
63 | 2 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 777 | 26841271 |
EU |
59 | 2 |
Erythema, Back pain, Pruritus, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 778 | 26841282 |
US |
1 | |
Arthropod bite, Erythema, |
||||
EVOLOCUMAB, |
||||
| 779 | 26841388 |
US |
33 | 1 |
Pruritus, Skin burning sensation, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 780 | 26841419 |
CO |
63 | 1 |
Colorectal cancer metastatic, Large intestinal obstruction, Pain, Erythema, Rash, Skin toxicity, Burning sensation, Skin lesion, Skin exfoliation, Dry skin, Scab, Pruritus, Pain of skin, |
||||
PANITUMUMAB, |
||||
| 781 | 26841496 |
EU |
61 | 2 |
Erythema, Nausea, Chest pain, Infusion related reaction, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 782 | 26841633 |
CA |
34 | |
Harvey-Bradshaw index increased, Arthralgia, Chest discomfort, Symptom recurrence, Drug level abnormal, Swollen tongue, Erythema, Hypersensitivity, Dyspnoea, Rash, Infusion site rash, Pruritus, Rash, Off label use, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 783 | 26841658 |
US |
6 | 2 |
Peripheral swelling, Erythema, Injection site reaction, |
||||
| 784 | 26841972 |
US |
2 | |
Body temperature increased, Feeling abnormal, Flushing, Erythema, Pruritus, Rash, |
||||
MAVACAMTEN, |
||||
| 785 | 26842242 |
EU |
69 | 2 |
Laryngeal oedema, Erythema, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 786 | 26842325 |
US |
72 | 2 |
Localised infection, Limb operation, Infected bite, Pain, Arthropod bite, Erythema, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 787 | 26842328 |
BR |
54 | 1 |
Pruritus, Hyperaemia, Paraesthesia, Erythema, Infusion related reaction, |
||||
USTEKINUMAB, MESALAMINE, EZETIMIBE, ROSUVASTATIN, |
||||
| 788 | 26842435 |
US |
24 | 2 |
Fungal infection, Skin exfoliation, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 789 | 26842443 |
RU |
6 | |
Erythema, Peripheral swelling, Hyperaemia, Facial paresis, Subarachnoid haematoma, Subarachnoid haemorrhage, Cerebral ischaemia, Jaundice, Peripheral vein thrombosis, Anaemia, Neutrophilia, Aspartate aminotransferase increased, C-reactive protein increased, Blood bilirubin increased, Coordination abnormal, Balance disorder, Speech disorder, Condition aggravated, Rash, Contusion, Hyperfibrinogenaemia, Activated partial thromboplastin time prolonged, Prothrombin time prolonged, International normalised ratio increased, Prothrombin time shortened, Eyelash discolouration, |
||||
TOVORAFENIB, TOVORAFENIB, |
||||
| 790 | 26842521 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Erythema, Asthma, |
||||
OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IVABRADINE, HYDROXYCHLOROQUINE, TIZANIDINE HYDROCHLORIDE, TACROLIMUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOLIC ACID, |
||||
| 791 | 26842725 |
CA |
70 | |
Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Erythema, Heart rate decreased, Lip erythema, Lip swelling, Oxygen saturation decreased, Respiratory rate increased, Swelling, Swelling face, Swollen tongue, Tongue erythema, Headache, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, AMLODIPINE, AMLODIPINE, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 792 | 26842790 |
US |
1 | |
Illness, Dermatitis atopic, Erythema, Dry skin, |
||||
DUPILUMAB, FLUOCINOLONE ACETONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 793 | 26842865 |
CA |
31 | 1 |
Erythema, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, |
||||
| 794 | 26842987 |
US |
62 | 1 |
Blister, Skin burning sensation, Erythema, |
||||
BUPRENORPHINE, NABUMETONE, |
||||
| 795 | 26843026 |
GB |
71 | 2 |
Pemphigoid, Pruritus, Erythema, Blister, Joint swelling, |
||||
CYANOCOBALAMIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, |
||||
| 796 | 26843040 |
US |
73 | 1 |
Nausea, Erythema, Device leakage, |
||||
BUPRENORPHINE, |
||||
| 797 | 26843079 |
1 | ||
Erythema, Enuresis, Accident, Respiration abnormal, Nightmare, Tinnitus, Product dose omission issue, Product administration interrupted, Chest discomfort, Paraesthesia, Headache, Fatigue, Somnolence, Palpitations, Anxiety, Initial insomnia, |
||||
MODAFINIL, SODIUM OXYBATE, PITOLISANT HYDROCHLORIDE, SODIUM OXYBATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 798 | 26843161 |
EU |
72 | 1 |
Oculogyric crisis, Musculoskeletal stiffness, Peripheral swelling, Condition aggravated, Skin irritation, Erythema, Pruritus, Bruxism, Abnormal behaviour, Malaise, On and off phenomenon, Cough, Nausea, Vomiting, Dyskinesia, Therapeutic product effect decreased, Treatment noncompliance, Wrong technique in product usage process, Wrong technique in device usage process, Product use issue, Incorrect dose administered by device, Product communication issue, Device occlusion, Product residue present, Product physical issue, Device issue, |
||||
RIVASTIGMINE, RIVASTIGMINE, RIVASTIGMINE, RIVASTIGMINE, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, SAFINAMIDE MESYLATE, OPICAPONE, OPICAPONE, OPICAPONE, OPICAPONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RIVASTIGMINE, RIVASTIGMINE, RIVASTIGMINE, RIVASTIGMINE, |
||||
| 799 | 26843266 |
CN |
80 | 1 |
Skin hyperplasia, Dizziness, Fall, Dermatitis exfoliative generalised, Erythema, Sleep disorder due to a general medical condition, Rash, |
||||
DUPILUMAB, METHYLPREDNISOLONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIUM CARBONATE, ANTACID, ERGOCALCIFEROL, DIMETHICONE, BODY SHIELD, BODY CLEANSER, SKIN PROTECTANT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 800 | 26843291 |
US |
62 | 2 |
Pruritus, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30